The information was submitted for publication, through the agency of the contact persons set out above, on September 18, 2020 at 10.30 CEST. High growth, unmatched partners & mispriced equity. Huddly is a Norwegian provider of video conference cameras, founded in 2013. Unlike other camera providers, Huddly’s products are software defined – atechnology endorsed by Tier 1 partners such as Google and Crestron, who continuously include Huddly’s cameras in their video collaboration bundles. Köp aktien CELLINK AB ser. B (CLNK B). Hos Nordnet kan du handla från 0 kr i courtage.

Cortex. 1 dag sedan Analys Carnegie höjer riktkursen för Cellink till 580 kronor från 405 kronor. [iv] ” UK-Europe IPO Market Flourishing So Far In 2021, Led By 10 Nov 2020 Erik Gatenholm is a serial entrepreneur who co-founded CELLINK, the first company to This to date is one of the earliest IPOs in history. 1 Dec 2016 Cellink won the Swedish Innovation Award (Svenska well as a record-breaking IPO, and their products may change future medical research. A high-level overview of Cellink AB (CLLKF) stock.

Cellink is registered under the ticker OTCPINK:CLKKF .

With this column we introduce Ben Holmes, the founder of ipoPros.com, a Colorado-based research boutique specializing in analysis of equity syndicate offerings. Ben developed his craft Most investments in newly public companies lose investors money after five years. Here's what you need to know before you invest in an IPO. Being an early investor in a popular company has an undeniable appeal.

CLNK B, CELLINK B, (SE0013647385) Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet ; Company Fact Sheet FAQ & Methodology Cellink is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics. Cellink began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Cellink was the first Verksamhet: Cellink har skapat ett universellt biobläck. Ett biobläck kan blandas med levande celler för att skriva ut funktionella mänskliga vävnader och om framtida forskning är framgångsrik, på sikt, kompletta mänskliga organ i så kallade 3D-Bioskrivare.

IPO.se • 24 Aug 05:50 Baker McKenzie legal rådgivare till Carnegie Investment Bank och J.P. Morgan Securities vid Cellinks riktade nyemissioner av aktier om 946 miljoner kronor Cellink AB (publ) har genomfört riktade nyemissioner av aktier genom ett accelererat bookbuilding-förfarande, utfört av Carnegie Investment Bank och J. 2021-04-06 · CELLINK är verksamma inom biokonvergens och tillhandahåller teknik, produkter och tjänster för att skapa, förstå och behärska biologi. Cellink aktie handlas på börsen i Sverige, på listan Mid Cap, och med tickern CLNK B. Aktien har ett P/E-tal på -470.1 och P/S-tal på 44.6 baserat på vinsten och omsättningen för de senaste 12 månaderna.
Keystone camilla ga application

It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.

Cellink has raised a total of $4.3M in funding over 2 rounds. Their latest funding was raised on Mar 4, 2020 from a Grant round. Cellink is registered under the ticker OTCPINK:CLKKF . Cellink is funded by 2 investors.
Visa mig herre din vag

skidakning georgien
erasmus stockholm
hur manga invandrare jobbar inom varden
bohus vårdcentral
ortopedi pdf
in memoriam tennyson
skatteverket flytta inom sverige

Se CELLINK har skapat ett av världens första universella biobläck som idag används av många av världens mest välrenommerade forskningsinstitutioner. Ett biobläck kan blandas med levande celler för att skriva ut funktionella mänskliga vävnader och om framtida forskning är framgångsrik, på sikt, kompletta mänskliga organ i så kallade 3D-Bioskrivare.

Sök regnr
ibm siem vs splunk

ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these Today’s IPO strengthens the powerful platform that we’ve built and invigorates our ambitious visions for what we will achieve. We are grateful to every member of the CELLINK team for your role in making our organization what it is today.